Skip to main content
Clinical Trials/NL-OMON34868
NL-OMON34868
Completed
Not Applicable

Perceval S valve clinical trial for extended CE-mark - CAVALIER study

Sorin Biomedica CRM SR0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic valve stenosis/insufficiency
Sponsor
Sorin Biomedica CRM SR
Enrollment
45
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Sorin Biomedica CRM SR

Eligibility Criteria

Inclusion Criteria

  • Subjects of age 65 (or older) years;
  • Subjects with aortic valve stenosis or steno\-insufficiency;
  • Subjects in which preoperative evaluation indicated the need for native or
  • prosthetic aortic valve replacement with a biological prosthesis;

Exclusion Criteria

  • Subjects involved in any other clinical study for drugs or devices;
  • Subjects with a previously implanted Perceval S prosthesis, within the clinical study, that requires replacement;
  • Subjects with previous implantation of valve prostheses or annuloplasty ring not being replaced by the study valve;
  • Subjects requiring simultaneous cardiac procedures, apart from septal myectomy and/or coronary by\-pass;
  • Subjects who require double or multiple valve replacement or repair;
  • Subjects with aneurysmal dilation or dissection of the ascending aortic wall;
  • Subjects with active endocarditis, myocarditis;
  • Subjects with congenital bicuspid aortic valve;
  • Subjects with myocardial infarction \< 90 days before the planned valve implant surgery;
  • Subjects with known hypersensitivity to nickel alloys.

Outcomes

Primary Outcomes

Not specified

Similar Trials